| 
MechanismTubulin inhibitors   | 
 | 
 | 
 | 
 | 
Drug Highest PhaseApproved  | 
First Approval Ctry. / Loc.China   | 
First Approval Date01 Jan 1995  | 
 | 
MechanismCav2.1 inhibitors   | 
 | 
 | 
 | 
 | 
Drug Highest PhaseApproved  | 
First Approval Ctry. / Loc.Japan   | 
First Approval Date01 May 1981  | 
100 Clinical Results associated with Hikma International Pharmaceuticals LLC
0  Patents (Medical) associated with Hikma International Pharmaceuticals LLC
100 Deals associated with Hikma International Pharmaceuticals LLC
100 Translational Medicine associated with Hikma International Pharmaceuticals LLC